HALE DAVID F
Insider CIK 1024004 · BIOC Chairman, Director · MITI Director · SNTS Director · ONCT Director · SOMX Director · CNAT Director · DRMA Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 2,500 | — | $0 | 2,500 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2025-01-23 | 2025-01-23 | 78,741 | — | $0 | 80,957 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 78,741 | — | $0 | 78,741 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2025-01-13 | 2025-01-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-06-20 | 2024-06-24 | 3,300 | — | $0 | 3,300 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2024-02-23 | 2024-02-27 | 266 | $9.04 | $2.4K | 29,673 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2024-02-23 | 2024-02-27 | 714 | $9.04 | $6.5K | 714 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2024-01-04 | 2024-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-06-28 | 2023-06-30 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-10-06 | 2022-10-07 | 30,155 | — | $0 | 75,720 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-07-07 | 2022-07-08 | 26,441 | — | $0 | 45,565 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-06-16 | 2022-06-17 | 37,500 | — | $0 | 37,500 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award | 2022-04-07 | 2022-04-08 | 15,466 | — | $0 | 19,124 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2021-12-09 | 2021-12-10 | 363 | $4.06 | $1.5K | 3,114 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2021-12-09 | 2021-12-10 | 11 | $4.07 | $45 | 101 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2021-12-09 | 2021-12-10 | 71 | $4.07 | $289 | 796 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 555,622 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 3,048 | — | $0 | 3,048 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 62,500 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy deriv | 2021-08-17 | 2021-08-17 | 35,714 | — | $0 | 35,714 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 3,571,428 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 410,000 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 250,000 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion deriv | 2021-08-17 | 2021-08-17 | 302,112 | — | $0 | 0 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 20,000 | — | $0 | 331,606 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 27,103 | — | $0 | 532,925 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 174,216 | — | $0 | 505,822 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | P Buy | 2021-08-17 | 2021-08-17 | 35,714 | — | $0 | 35,714 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 12,195 | — | $0 | 311,606 | SEC↗ |
| DRMA Dermata Therapeutics, Inc. | C Conversion | 2021-08-17 | 2021-08-17 | 44,777 | — | $0 | 299,411 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2021-07-16 | 2021-07-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | S Sale | 2021-06-30 | 2021-07-02 | 3,669 | $4.75 | $17.4K | 713,152 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2021-05-25 | 2021-05-27 | 37,500 | — | $0 | 37,500 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2020-06-12 | 2020-06-12 | 445 | $0.55 | $245 | 112 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2020-06-12 | 2020-06-12 | 159 | $0.56 | $89 | 3,477 | SEC↗ |
| BIOC BIOCEPT INC | S Sale | 2020-06-12 | 2020-06-12 | 556 | $0.56 | $311 | 867 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-07-31 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2020-06-11 | 2020-06-12 | 22,500 | — | $0 | 22,500 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2020-06-05 | 2020-06-09 | 500 | — | $0 | 500 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy deriv | 2020-05-21 | 2020-05-22 | 8,706 | — | $0 | 8,706 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2020-05-21 | 2020-05-22 | 17,412 | — | $0 | 716,818 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2020-07-31 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2019-09-12 | 2019-09-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2019-06-27 | 2019-07-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2019-06-17 | 2019-06-19 | 500 | — | $0 | 500 | SEC↗ |
| ONCT GTX INC /DE/ | A Award deriv | 2019-06-07 | 2019-06-11 | 3,292 | — | $0 | 3,292 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 18,346 | — | $0 | 18,346 | SEC↗ |
| ONCT GTX INC /DE/ | A Award | 2019-06-07 | 2019-06-11 | 699,406 | — | $0 | 699,406 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2019-04-30 | 2019-06-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2018-06-29 | 2018-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2017-06-22 | 2017-06-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2017-03-31 | 2017-04-03 | 4,166 | — | $0 | 4,166 | SEC↗ |
| BIOC BIOCEPT INC | P Buy deriv | 2016-10-19 | 2016-10-21 | 90,909 | — | $0 | 90,909 | SEC↗ |
| BIOC BIOCEPT INC | P Buy | 2016-10-19 | 2016-10-21 | 90,909 | $1.10 | $100.0K | 109,099 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2016-06-23 | 2016-06-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| BIOC BIOCEPT INC | G Gift | 2016-06-16 | 2016-10-21 | 13,334 | — | $0 | 18,190 | SEC↗ |
| BIOC BIOCEPT INC | G Gift | 2016-06-16 | 2016-10-21 | 13,334 | — | $0 | 16,736 | SEC↗ |
| BIOC BIOCEPT INC | P Buy deriv | 2016-05-04 | 2016-05-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BIOC BIOCEPT INC | P Buy | 2016-05-04 | 2016-05-05 | 50,000 | $1.00 | $50.0K | 138,356 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2015-12-31 | 2016-01-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise deriv | 2015-11-09 | 2015-11-10 | 10,204 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise deriv | 2015-11-09 | 2015-11-10 | 53,662 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise | 2015-11-09 | 2015-11-10 | 53,662 | — | $0 | 88,356 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise | 2015-11-09 | 2015-11-10 | 10,204 | — | $0 | 34,694 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise deriv | 2015-08-24 | 2015-08-25 | 14,286 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise | 2015-08-24 | 2015-08-25 | 14,286 | — | $0 | 24,490 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2015-06-11 | 2015-06-15 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BIOC BIOCEPT INC | P Buy deriv | 2015-02-13 | 2015-02-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| BIOC BIOCEPT INC | P Buy | 2015-02-13 | 2015-02-18 | 40,000 | $1.25 | $50.0K | 94,570 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2014-06-19 | 2014-06-23 | 35,000 | — | $0 | 35,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2014-02-21 | 2014-02-24 | 53,108 | — | $0 | 53,108 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2014-02-13 | 2014-02-18 | 70,000 | — | $0 | 70,000 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 10,204 | — | $0 | 10,204 | SEC↗ |
| BIOC BIOCEPT INC | C Conversion deriv | 2014-02-10 | 2014-02-12 | 47,181 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 53,662 | — | $0 | 53,662 | SEC↗ |
| BIOC BIOCEPT INC | E Expire deriv | 2014-02-10 | 2014-02-12 | 10,204 | $4.62 | $47.1K | 0 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 22,175 | — | $0 | 22,175 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 36,302 | — | $0 | 36,302 | SEC↗ |
| BIOC BIOCEPT INC | C Conversion | 2014-02-10 | 2014-02-12 | 47,181 | $10.00 | $471.8K | 54,570 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2014-01-08 | 2014-01-10 | 12,121 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2014-01-08 | 2014-01-10 | 12,121 | $0.99 | $12.0K | 24,242 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 42,000 | $28.88 | $1.21M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 42,000 | $10.07 | $422.9K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 42,000 | $25.27 | $1.06M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 10,000 | $22.55 | $225.5K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 32,000 | $28.67 | $917.4K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 42,000 | $26.68 | $1.12M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 25,000 | $23.00 | $575.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 25,000 | $22.00 | $550.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 25,000 | $29.00 | $725.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 40,000 | $25.27 | $1.01M | 0 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 18,000 | $32.00 | $576.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 130,739 | $32.00 | $4.18M | 0 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 164,713 | $32.00 | $5.27M | 0 | SEC↗ |
| SNTS SANTARUS INC | U Tender | 2014-01-02 | 2014-01-06 | 5,000 | $32.00 | $160.0K | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise deriv | 2013-09-26 | 2013-09-27 | 12,121 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | M Exercise | 2013-09-26 | 2013-09-27 | 12,121 | $2.31 | $28.0K | 12,121 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | A Award deriv | 2013-07-30 | 2013-08-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion deriv | 2013-07-30 | 2013-08-01 | 162,356 | — | $0 | 0 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | J Other | 2013-07-30 | 2013-08-01 | 261 | $11.00 | $2.9K | 141,151 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | P Buy | 2013-07-30 | 2013-08-01 | 2,588 | $11.00 | $28.5K | 143,739 | SEC↗ |
| CNAT Conatus Pharmaceuticals In | C Conversion | 2013-07-30 | 2013-08-01 | 19,679 | — | $0 | 140,890 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 42,000 | — | $0 | 42,000 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 70,388 | — | $0 | 0 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 40,098 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 16,033 | — | $0 | 70,388 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-12-12 | 2012-12-13 | 42,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-12-12 | 2012-12-13 | 42,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-12-12 | 2012-12-13 | 42,000 | $2.47 | $103.7K | 304,452 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-12-12 | 2012-12-13 | 42,000 | $2.02 | $84.8K | 262,452 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 137,586 | — | $0 | 434,845 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 144,951 | — | $0 | 297,259 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2012-06-13 | 2012-06-14 | 42,000 | — | $0 | 42,000 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award deriv | 2012-05-31 | 2012-06-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-04-02 | 2012-04-04 | 152,308 | — | $0 | 152,308 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-21 | 2012-03-22 | 11,428 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-21 | 2012-03-22 | 4,285 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-21 | 2012-03-22 | 32,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2012-03-21 | 2012-03-22 | 42,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 5,779 | $5.34 | $30.9K | 7,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 4,000 | $5.35 | $21.4K | 16,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 1,000 | $5.34 | $5.3K | 12,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 2,000 | $5.34 | $10.7K | 11,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 1,000 | $5.35 | $5.3K | 9,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 1,000 | $5.35 | $5.3K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 2,000 | $5.34 | $10.7K | 18,000 | SEC↗ |
| SNTS SANTARUS INC | P Buy | 2012-03-21 | 2012-03-22 | 1,221 | $5.34 | $6.5K | 1,221 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-21 | 2012-03-22 | 42,000 | $2.38 | $100.0K | 220,452 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-21 | 2012-03-22 | 32,000 | $1.18 | $37.8K | 178,452 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-21 | 2012-03-22 | 4,285 | $1.23 | $5.3K | 146,452 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2012-03-21 | 2012-03-22 | 11,428 | $0.88 | $10.1K | 142,167 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 50,000 | $6.56 | $328.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 83,333 | $1.10 | $91.7K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 68,182 | $1.10 | $75.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 50,000 | $2.54 | $127.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 33,333 | $2.39 | $79.7K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 70,000 | $4.37 | $305.9K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 30,000 | $8.67 | $260.1K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 30,000 | $8.25 | $247.5K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 150,000 | $7.84 | $1.18M | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 50,000 | $5.47 | $273.5K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 30,000 | $4.11 | $123.3K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 150,000 | $4.34 | $651.0K | 0 | SEC↗ |
| MITI MICROMET, INC. | D To issuer deriv | 2012-03-07 | 2012-03-09 | 30,000 | $6.49 | $194.7K | 0 | SEC↗ |
| MITI MICROMET, INC. | U Tender | 2012-03-02 | 2012-03-06 | 103,786 | $11.00 | $1.14M | 0 | SEC↗ |
| MITI MICROMET, INC. | U Tender | 2012-03-02 | 2012-03-06 | 18,165 | $11.00 | $199.8K | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | G Gift | 2011-08-30 | 2012-04-04 | 2,200 | — | $0 | 320,787 | SEC↗ |